Gold Industry Partner: Novartis


NOTE: IAPO is in no way responsible for the content of the Industry Partner profiles.  These have been produced using information provided by the Industry Partners.

Novartis is committed to the research and development of innovative products to protect and improve health and well-being, operating in the areas of pharmaceuticals, consumer health, generics and eye-care.  Novartis Pharmaceuticals aims to provide a broad portfolio of innovative, effective and safe products and services to patients through healthcare professionals around the world.  Areas of particular focus include oncology, cardiovascular, central nervous system, gastroenterology, dermatology, and rheumatology.

As a corporate citizen, Novartis is committed to promoting research, education and development projects all over the world.  In addition, they are strong supporters of organizations that seek to educate and represent patients, such as IAPO.